Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Neoplasm”

6,030 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,030 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)Looking for participantsNCT06520488
What this trial is testing

HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 118
Early research (Phase 1)Study completedNCT00006254
What this trial is testing

VNP20009 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT00734305
What this trial is testing

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Who this might be right for
Advanced Solid Tumors
Merrimack Pharmaceuticals 44
Early research (Phase 1)Study completedNCT01598129
What this trial is testing

ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

Who this might be right for
Malignant Solid Tumour
Targovax Oy 12
Early research (Phase 1)Study completedNCT00448396
What this trial is testing

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Novartis Pharmaceuticals 17
Early research (Phase 1)Looking for participantsNCT06859762
What this trial is testing

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd. 220
Early research (Phase 1)Study completedNCT02454062
What this trial is testing

A Trial of TAS-114 in Combination With S-1

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 120
Early research (Phase 1)Study completedNCT03713905
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd. 293
Early research (Phase 1)Study completedNCT02095054
What this trial is testing

Regorafenib and Cetuximab in Patients With Advanced Malignancy

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT05101070
What this trial is testing

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 282
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT04349969
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 38
Early research (Phase 1)Study completedNCT02482441
What this trial is testing

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Who this might be right for
Advanced Relapsed TumorsRefractory Solid Tumors
OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Early research (Phase 1)Study completedNCT04087018
What this trial is testing

Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Arcus Biosciences, Inc. 18
Early research (Phase 1)Not Yet RecruitingNCT07196579
What this trial is testing

Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Cancer
TCRx Therapeutics Co.Ltd 30
Early research (Phase 1)Study completedNCT01004861
What this trial is testing

Safety Study of PLX108-01 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Daiichi Sankyo 132
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)Looking for participantsNCT06410703
What this trial is testing

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumor
Canwell Biotech Limited 71
Load More Results